Erasca to Present at the Bank of America Securities Health Care Conference
Erasca Insider Purchases Yet To Pay Off Regardless Of Recent Strength
H.C. Wainwright Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $6
Erasca Price Target Maintained With a $6.00/Share by HC Wainwright & Co.
Erasca Analyst Ratings
Erasca Presents New RAS-targeting Franchise Data at AACR Meeting
Express News | Erasca Presents New Preclinical Data For Profiles Of RAS-Targeting Franchise At 2025 AACR Annual Meeting
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Erasca (ERAS)
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
Is Erasca Inc. (NASDAQ:ERAS) the Best Biotech Penny Stock to Buy According to Hedge Funds?
Erasca Slides As Insider Purchases Lose Another US$84k
Morgan Stanley Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $4
Morgan Stanley Keeps Their Buy Rating on Erasca (ERAS)
Erasca (ERAS) Gets a Buy From J.P. Morgan
New Analyst Forecast: $ERAS Given $5.0 Price Target
Raymond James Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $5
This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Raymond James Initiates Erasca at Outperform With $5 Price Target
Analysts Are Bullish on Top Healthcare Stocks: Vera Therapeutics (VERA), Erasca (ERAS)
BofA Securities Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $5